Model
Edge
RVL Pharmaceuticals
0001754526
Filing Type
4
Filing Date
10/22/2023
Updated
10/23/23, 10:23 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership